Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.

776 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Immune clearance of highly pathogenic SIV infection (2013, positive): “Taken together, these data indicate that (1) RhCMV/SIV vector-elicited immune responses can mediate protection regardless of the route of SIV challenge, (2) viral control is both local and systemic, and (3) replication-competent SIV can persist in several sites for weeks to months in protected RM (e”
Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. (2007, background): “For example, some evidence implies that IL-7R might also be a marker for Th1 CD4 T cells (Dooms et al., 2007; Kondrack et al., 2003; Li et al., 2003; Purton et al., 2007), but it remains to be seen whether this will apply to all effector T cell lineages (e.”